Cargando…
Dual-targeting inhibition of TNFR1 for alleviating rheumatoid arthritis by a novel composite nucleic acid nanodrug
Selective suppression of tumor necrosis factor (TNF) α-TNF receptor 1 (TNFR1) signaling is a potent solution for rheumatoid arthritis (RA). Herein, novel composite nucleic acid nanodrugs that simultaneously restrain TNF α binding and TNFR1 multimerization were designed to reinforce inhibition of TNF...
Autores principales: | Wang, Xiaonan, Guo, Fanfan, Zhang, Yi, Wang, Ziyi, Wang, Jiaqi, Luo, Rongrong, Chu, Xiao, Zhao, Yongxing, Sun, Pengchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314200/ https://www.ncbi.nlm.nih.gov/pubmed/37396624 http://dx.doi.org/10.1016/j.ijpx.2023.100162 |
Ejemplares similares
-
Dual-Drug Loaded Separable Microneedles for Efficient Rheumatoid Arthritis Therapy
por: An, Mengchen, et al.
Publicado: (2022) -
Peptide-anchored neutrophil membrane-coated biomimetic nanodrug for targeted treatment of rheumatoid arthritis
por: Yang, Ni, et al.
Publicado: (2023) -
Nanodrugs alleviate acute kidney injury: Manipulate RONS at kidney
por: Chen, Qiaohui, et al.
Publicado: (2022) -
Editorial: Engineering Nucleic Acids-Based Functional Nanomaterials, Nanodrugs, and Biosensors
por: Jouha, Jabrane, et al.
Publicado: (2022) -
Microneedle-Assisted Transdermal Delivery of Etanercept for Rheumatoid Arthritis Treatment
por: Cao, Jian, et al.
Publicado: (2019)